A study investigating incidences of De Novo donor specific antibodies (DSA) after Alemtuzumab induction in renal transplant recipients
Latest Information Update: 14 Oct 2016
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 14 Oct 2016 New trial record